Pozzari M - Search Results

1

Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis.

Pozzari M, Maisonneuve P, Spada F, Berruti A, Amoroso V, Cella CA, Laffi A, Pellicori S, Bertani E, Fazio N. Pozzari M, et al. Cancer Treat Rev. 2018 Dec;71:39-46. doi: 10.1016/j.ctrv.2018.10.008. Epub 2018 Oct 13. Cancer Treat Rev. 2018. PMID: 30352319 Review.

2

Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis.

Rebelatto TF, Falavigna M, Pozzari M, Spada F, Cella CA, Laffi A, Pellicori S, Fazio N. Rebelatto TF, et al. Among authors: pozzari m. Cancer Treat Rev. 2019 Nov;80:101895. doi: 10.1016/j.ctrv.2019.101895. Epub 2019 Sep 6. Cancer Treat Rev. 2019. PMID: 31542591

3

Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series.

Fazio N, Maisonneuve P, Spada F, Gervaso L, Cella CA, Pozzari M, Zerini D, Pisa E, Fumagalli C, Barberis M, Laffi A, Grana C CM, Orsolini G, Prestianni P, Bonomo G, Funicelli L, Bertani E, Queirolo P, Ravizza D, Rubino M, Tosti G, Pennacchioli E. Fazio N, et al. Among authors: pozzari m. Cancers (Basel). 2022 Sep 29;14(19):4777. doi: 10.3390/cancers14194777. Cancers (Basel). 2022. PMID: 36230698 Free PMC article.

4

Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case.

Roca E, Pozzari M, Vermi W, Tovazzi V, Baggi A, Amoroso V, Nonnis D, Intagliata S, Berruti A. Roca E, et al. Among authors: pozzari m. Lung Cancer. 2019 Jan;127:12-18. doi: 10.1016/j.lungcan.2018.11.016. Epub 2018 Nov 13. Lung Cancer. 2019. PMID: 30642539 Review.

5

Early taxane exposure and neurotoxicity in breast cancer patients.

Cimbro E, Dessì M, Ziranu P, Madeddu C, Atzori F, Lai E, Pretta A, Mariani S, Donisi C, Spanu D, Pozzari M, Murgia S, Saba G, Codipietro C, Palmas E, Sanna G, Semonella F, Sardo S, Finco G, Scartozzi M. Cimbro E, et al. Among authors: pozzari m. Support Care Cancer. 2024 Oct 8;32(10):709. doi: 10.1007/s00520-024-08908-2. Support Care Cancer. 2024. PMID: 39375221 Free PMC article.

6

CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors.

Ziranu P, Pretta A, Pozzari M, Maccioni A, Badiali M, Fanni D, Lai E, Donisi C, Persano M, Gerosa C, Puzzoni M, Bardanzellu F, Ambu R, Pusceddu V, Dubois M, Cerrone G, Migliari M, Murgia S, Spanu D, Pretta G, Aimola V, Balconi F, Murru S, Faa G, Scartozzi M. Ziranu P, et al. Among authors: pozzari m. Sci Rep. 2023 Mar 16;13(1):4397. doi: 10.1038/s41598-023-31538-3. Sci Rep. 2023. PMID: 36928082 Free PMC article.

7

Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment.

Pretta A, Ziranu P, Giampieri R, Donisi C, Cimbro E, Spanu D, Lai E, Pecci F, Balconi F, Lupi A, Pozzari M, Persano M, Murgia S, Pusceddu V, Puzzoni M, Berardi R, Scartozzi M. Pretta A, et al. Among authors: pozzari m. Dig Liver Dis. 2023 May;55(5):655-660. doi: 10.1016/j.dld.2022.11.012. Epub 2022 Dec 10. Dig Liver Dis. 2023. PMID: 36513569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters